intravenous-intra-amniotic-utero-transplantation-murine

Intravenous and Intra-amniotic <em>In Utero</em> Transplantation in the Murine Model

In utero transplantation (IUT) is a unique and versatile mode of therapy that can be used to introduce stem cells, viral vectors, or any other substances ...

Children's Hospital of Philadelphia

In utero hematopoietic cell transplantation (IUHCT) is a nonmyeloablative nonimmunosuppressive alternative to postnatal hematopoietic stem cell transplantation for the treatment of congenital hemoglobinopathies. Anti-HLA donor-specific Abs (DSA) are associated with a high incidence of graft rejection following postnatal hematopoietic stem cell transplantation. We determine if DSA present in the mother can similarly cause graft rejection in the fetus following IUHCT. Ten million C57BL/6 (B6, H2k) bone marrow cells were transplanted in utero into gestational day 14 BALB/c (H2k) fetuses. The pregnant BALB/c dams carrying these fetuses either had been previously sensitized to B6 Ag or were injected on gestational days 13-15 with serum from B6-sensitized BALB/c females. Maternal-fetal Ab transmission, Ab opsonization of donor cells, chimerism, and frequency of macrochimeric engraftment (chimerism >1%) were assessed by flow cytometry. Maternal IgG was transmitted to the fetus and rapidly opsonized donor cells following IUHCT. Donor cell rejection was observed as early as 4 h after IUHCT in B6-sensitized dams and 24 h after IUHCT in dams injected with B6-sensitized serum. Efficient opsonization was strongly correlated with decreased chimerism. No IUHCT recipients born to B6-sensitized dams or dams injected with B6-sensitized serum demonstrated macrochimeric engraftment at birth compared with 100% of IUHCT recipients born to naive dams or dams injected with naive serum ( < 0.001). In summary, maternal donor-specific IgG causes rapid, complete graft rejection in the fetus following IUHCT. When a third-party donor must be used for clinical IUHCT, the maternal serum should be screened for DSA to optimize the chance for successful engraftment.

Barbara E. Coons

Division of General,
Thoracic,
and Fetal Surgery,
Center for Fetal Research,
Division of General, Thoracic, and Fetal Surgery, Center for Fetal Research

Children's Hospital of Philadelphia

Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model

Barbara E. Coons

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Division of General,Thoracic,and Fetal Surgery,Center for Fetal Research,Division of General, Thoracic, and Fetal Surgery, Center for Fetal Research

Children's Hospital of Philadelphia

Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model

Division of General,
Thoracic,
and Fetal Surgery,
Center for Fetal Research,
Division of General, Thoracic, and Fetal Surgery, Center for Fetal Research